Richard G. Vincent, Chief Financial Officer at Oncternal Therapeutics, Inc. (ONCT), bought 12,500 shares at $1.65 ($22K) on 2022-01-28, disclosed to the SEC on 2022-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.70 | 5,000 | $9K | 39.3% |
| 2 | $1.80 | 5,000 | $9K | 41.6% |
| 3 | $1.65 | 2,500 | $4K | 19.1% |
| Total | $1.73 avg | 12,500 | $22K | 100% |
| Filing → |